Human chorionic gonadotropin (hCG) is produced by trophoblastic tissue and it appears around the 8-9th day after ovulation where fertilization has occurred, or around the 4th day after conception.

In a 28 day cycle with ovulation occurring at day 14, hCG can be detected in urine or serum in minute quantities around day 23, or 5 days before the expected menstruation. Its function includes facilitation of implantation as well as maintenance and development of the corpus luteum.

The hormone concentration doubles approximately every 2 days and peaks between concentration of 50,000 mIU/ml. Concentrations as high as 100,000 mIU/ normal subjects, hCG in urine provides an early indication of pregnancy.

One-step hCG Pregnancy Test

Intended Use
The One-step Pregnancy Test is a qualitative colloidal gold/antibody based immunoassay for rapid detection of human Chorionic Gonadotropin (hCG) in urine or serum samples. The test has a sensitivity of 25mIU/ml, making it an effective aid in the early detection of pregnancy.

Human chorionic gonadotropin (hCG) is produced by trophoblastic tissue and it appears around the 8-9th day after ovulation where fertilization has occurred, or around the 4th day after conception.

In a 28 day cycle with ovulation occurring at day 14, hCG can be detected in urine or serum in minute quantities around day 23, or 5 days before the expected menstruation. Its function includes facilitation of implantation as well as maintenance and development of the corpus luteum.

The hormone concentration doubles approximately every 2 days and peaks between concentration of 50,000 mIU/ml. Concentrations as high as 100,000 mIU/ normal subjects, hCG in urine provides an early indication of pregnancy.

One-step hCG Pregnancy Test

Intended Use
The One-step Pregnancy Test is a qualitative colloidal gold/antibody based immunoassay for rapid detection of human Chorionic Gonadotropin (hCG) in urine or serum samples. The test has a sensitivity of 25mIU/ml, making it an effective aid in the early detection of pregnancy.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

QuikRead go wrCRP is a rapid test for the quantitative determination of C-reactive protein (CRP) values in whole blood, serum, and plasma with QuikRead go instrument.

QuikRead go wrCRP gives reliable wide range CRP results within minutes.

Wide range CRP testing with QuikRead go wrCRP
C-reactive protein (CRP) is a widely used analyte to help assess the severity of bacterial infection, guide diagnostic and treatment decisions, and monitor response to antibiotic treatment in various healthcare settings 1,2. QuikRead go wrCRP test helps to identify patients who benefit from antibiotics, it helps in monitoring the treatment outcome, and can be used to test for low level inflammation.

CRP point of care testing drives sustainable use of antibiotics and antimicrobial stewardship in healthcare.